AICAR vs MOTS-c
MOTS-c is a 16-amino acid mitochondrial-derived peptide that also activates AMPK. Unlike AICAR, MOTS-c is an actual peptide, encoded by mitochondrial DNA and naturally produced in response to exercise. The activation pathway diff…
Topic resource collection
aicar peptide benefits Comparisons
Approved comparison material connected to this topic.
6 resourcesRead both sides
Comparison guides
Read comparison →
AICAR vs 5-amino-1MQ
5-amino-1MQ is another compound of interest in metabolic research, though it works through NNMT inhibition rather than AMPK activation. While both compounds address metabolic dysfunction, they target different nodes in the metabo…
AICAR vs GW501516
GW501516 is the other compound from the Salk Institute study. It works through PPARdelta activation rather than AMPK. While both are classified as exercise mimetics, they target different molecular pathways. In the original study…
AICAR vs SS-31
SS-31 (elamipretide) targets mitochondria directly by stabilizing cardiolipin in the inner mitochondrial membrane. While AICAR tells cells to make more mitochondria through AMPK and PGC-1alpha signaling, SS-31 improves the functi…
AICAR vs metformin
Metformin, the most widely prescribed diabetes medication globally, also activates AMPK but through a completely different mechanism. Metformin inhibits complex I of the mitochondrial electron transport chain, which increases the…
AICAR vs other AMPK activators and metabolic compounds
AICAR does not exist in isolation. Multiple compounds target AMPK or produce exercise-mimetic effects. Understanding how AICAR compares to alternatives helps researchers make informed decisions.